![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 18, 10863-10867, May 1, 1998
From the Inactivation of the human DNA repair protein,
O6-alkylguanine-DNA alkyltransferase (AGT), by
O6-benzylguanine renders tumor cells
susceptible to killing by alkylating agents. AGT mutants resistant to
O6-benzylguanine can be made by converting
Pro140 to an alanine (P140A) or Gly156 to an
alanine (G156A). These mutations had a much smaller effect on the
reaction with O6-benzylguanine when it was
incorporated into a short single-stranded oligodeoxyribonucleotide.
Such oligodeoxyribonucleotides could form the basis for the design of
improved AGT inhibitors. AGT and mutants P140A and G156A preferentially
reacted with O6-benzylguanine when incubated
with a mixture of two 16-mer oligodeoxyribonucleotides, one containing
O6-benzylguanine and the other,
O6-methylguanine. When the 6 amino acids
located in positions 159-164 in AGT were replaced by the equivalent
sequence from the Escherichia coli Ada-C protein (mutant
AGT/6ada) the preference for benzyl repair was eliminated. Further
mutation incorporating the P140A change into AGT/6ada giving mutant
P140A/6ada led to a protein that resembled Ada-C in preference for the
repair of methyl groups, but P140A/6ada did not differ from P140A in
reaction with the free base O6-benzylguanine.
Changes in the AGT active site pocket can therefore affect the
preference for repair of O6-benzyl or -methyl
groups when present in an oligodeoxyribonucleotide without altering the
reaction with free O6-benzylguanine.
Reaction of
O6-Benzylguanine-resistant Mutants of
Human O6-Alkylguanine-DNA
Alkyltransferase with
O6-Benzylguanine in
Oligodeoxyribonucleotides
,
,
,
Department of Cellular and Molecular
Physiology, Pennsylvania State University College of Medicine, The
Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033-0850, and
¶ ABL-Basic Research Program, National Cancer Institute-Frederick
Cancer Research and Development Center, Frederick, Maryland
21702-1201
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. J. Rasimas, S. R. Kar, A. E. Pegg, and M. G. Fried Interactions of Human O6-Alkylguanine-DNA Alkyltransferase (AGT) with Short Single-stranded DNAs J. Biol. Chem., February 2, 2007; 282(5): 3357 - 3366. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Mijal, S. Kanugula, C. C. Vu, Q. Fang, A. E. Pegg, and L. A. Peterson DNA Sequence Context Affects Repair of the Tobacco-Specific Adduct O6-[4-Oxo-4-(3-pyridyl)butyl]guanine by Human O6-Alkylguanine-DNA Alkyltransferases. Cancer Res., May 1, 2006; 66(9): 4968 - 4974. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zang, Q. Fang, A. E. Pegg, and F. P. Guengerich Kinetic Analysis of Steps in the Repair of Damaged DNA by Human O6-Alkylguanine-DNA Alkyltransferase J. Biol. Chem., September 2, 2005; 280(35): 30873 - 30881. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Pegg, K. Goodtzova, N. A. Loktionova, S. Kanugula, G. T. Pauly, and R. C. Moschel Inactivation of Human O6-Alkylguanine-DNA Alkyltransferase by Modified Oligodeoxyribonucleotides Containing O6-Benzylguanine J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 958 - 965. [Abstract] [Full Text] |
||||
![]() |
M. Xu-Welliver, J. Leitao, S. Kanugula, and A. E. Pegg Alteration of the Conserved Residue Tyrosine-158 to Histidine Renders Human O6-Alkylguanine-DNA Alkyltransferase Insensitive to the Inhibitor O6-Benzylguanine Cancer Res., April 1, 1999; 59(7): 1514 - 1519. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |